Remibrutinib in inadequately controlled cholinergic urticaria: a real-world case series

Duoqin Wang, Maorui Yi, Yiqi Zhu, Wenli Zhang, Sunyi Chen, Lin Xie, Hui Tang, Yanyun Shen

Open source

DOI
10.1016/j.jaad.2026.09.002
Published
2026-09
Container
Journal of the American Academy of Dermatology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jaad.2026.09.002,
  title = {Remibrutinib in inadequately controlled cholinergic urticaria: a real-world case series},
  author = {Duoqin Wang and Maorui Yi and Yiqi Zhu and Wenli Zhang and Sunyi Chen and Lin Xie and Hui Tang and Yanyun Shen},
  year = {2026},
  journal = {Journal of the American Academy of Dermatology},
  doi = {10.1016/j.jaad.2026.09.002},
  url = {https://doi.org/10.1016/j.jaad.2026.09.002}
}

RIS

TY  - JOUR
TI  - Remibrutinib in inadequately controlled cholinergic urticaria: a real-world case series
AU  - Duoqin Wang
AU  - Maorui Yi
AU  - Yiqi Zhu
AU  - Wenli Zhang
AU  - Sunyi Chen
AU  - Lin Xie
AU  - Hui Tang
AU  - Yanyun Shen
PY  - 2026
JO  - Journal of the American Academy of Dermatology
DO  - 10.1016/j.jaad.2026.09.002
UR  - https://doi.org/10.1016/j.jaad.2026.09.002
ER  - 

APA

Wang, D., Yi, M., Zhu, Y., Zhang, W., Chen, S., Xie, L., Tang, H., & Shen, Y. (2026). Remibrutinib in inadequately controlled cholinergic urticaria: a real-world case series. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.09.002

Source records